Route-Dependent Central Effects and Efficacy Prediction of a Nucleic Acid Drug: Comparison of ICV and IT Administration
The 99th Annual Meeting of the Japanese Pharmacological Society
Researcher Yuka Hasegawa from the Translational Research Business Unit to present a poster at the 53rd Annual Meeting of the Japanese Society of Toxicology
Yuka Hasegawa, a researcher from the Translational Research …
Gateway – Maximizing Human Predictability from In Vivo Pharmacology Studies
Join this webinar to find out how we can help accelerate your Drug Discovery! our first speaker will provide an overview of these approaches, followed by a case study on anti-obesity drug development presented by our second speaker.
Dr. Qinge Liang, a researcher from the Translational Research Business Unit, will have an oral and a poster presentation at the 53rd Annual Meeting of the Japanese Society of Toxicology
Dr. Qinge Liang, a researcher from the Translational …
Axcelead DDP Joins Lilly TuneLab to Advance AI Drug Discovery
Fujisawa, Japan, June 18, 2026 — Axcelead Drug …
Researcher Furukawa from the Discovery Technologies Business Unit to present a poster at the 53rd Annual Meeting of the Japanese Society of Toxicology (JSOT)
Researcher Furukawa from the Discovery Technologies Business Unit …
Enhancing Clinical Predictability through Human Disease-relevant Preclinical Models in CNS and Muscle Drug Discovery
Drug discovery for central nervous system (CNS) and muscle diseases continues to face major translational challenges. Conventional models often fail to capture human disease biology, while functional readouts can be difficult to reproduce, interpret, and translate into clinically meaningful outcomes.
Improving Preclinical Decision-Making in Obesity and CKD with Translational In Vivo Phenotyping
Subtitle : Join us to learn how in-depth in …
Improving Preclinical Decision-Making in Obesity and CKD with Translational In Vivo Phenotyping
Join this webinar to find out how we can help you identify promising novel leads! In this webinar, we will showcase our integrated HTS platform and share our successful track record. We will also highlight the latest advances powered by computational chemistry and AI/ML technologies.
BIO International Convention 2026
Boston, MA